Table 1 Non-COVID-19 outpatients with thyroid diseases
| Â | Hyper Sub (n. 19) Mean (St. Dev.) | Euthyroid (n. 57) Mean (St. Dev.) | Hypo Sub (n. 12) Mean (St. Dev.) | Hypo Overt (n. 7) Mean (St. Dev.) | Myxedema (n. 1) | Total (n. 96) Mean (St. Dev.) |
|---|---|---|---|---|---|---|
Sex (F/M) | 17/2 | 50/7 | 12/0 | 6/1 | 0/1 | 85/11 |
Age (years) | 55.7 (± 14.3) | 54.8 (± 14.8) | 49.2 (± 17.7) | 53.4 (± 20.3) | 78 | 54.4 (± 15.5) |
BMI | 25.8 (± 5.1) | 26.9 (± 5.7) | 24.4 (± 6.2) | 27.3 (± 9.0) | 27.6 | 26.4 (± 5.9) |
FT3 (pg/ml) | 3.2 (± 0.8) | 2.9 (± 0.4) | 2.7 (± 0.5) | 2.0 (± 0.6) | 1.7 | 2.9 (± 0.6) |
FT4 (ng/dl) | 1.4 (± 0.3) | 1.2 (± 0.3) | 1.1 (± 0.3) | 1.3 (± 1.1) | 0.4 | 1.2 (± 0.4) |
TSH (μIU/ml) | 0.1 (± 0.1) | 1.7 (± 0.8) | 6.3 (± 1.7) | 22.1 (± 10.1) | 100.0 | 4.5 (± 11.6) |